| Literature DB >> 22857656 |
Sven Gottwald1, Birgit Samans, Stefanie Lück, Wolfgang Friedt.
Abstract
BACKGROUND: Fusarium head blight (FHB) caused by Fusarium species like F. graminearum is a devastating disease of wheat (Triticum aestivum) worldwide. Mycotoxins such as deoxynivalenol produced by the fungus affect plant and animal health, and cause significant reductions of grain yield and quality. Resistant varieties are the only effective way to control this disease, but the molecular events leading to FHB resistance are still poorly understood. Transcriptional profiling was conducted for the winter wheat cultivars Dream (moderately resistant) and Lynx (susceptible). The gene expressions at 32 and 72 h after inoculation with Fusarium were used to trace possible defence mechanisms and associated genes. A comparative qPCR was carried out for selected genes to analyse the respective expression patterns in the resistant cultivars Dream and Sumai 3 (Chinese spring wheat).Entities:
Mesh:
Substances:
Year: 2012 PMID: 22857656 PMCID: PMC3533685 DOI: 10.1186/1471-2164-13-369
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Number of genes differentially expressed after comparisons of wheat GeneChip datasets at 32 and 72 h after inoculation (hai)
| | |||||
|---|---|---|---|---|---|
| | |||||
| Dream | | 871 | 924 | 1,056 | 681 |
| Dream | | 115 | 450 | 515 | 318 |
| Dream mock inoculated - Lynx mock inoculated | | 972 | 728 | * | * |
| Lynx | 218 | 204 | * | * | |
* Differentially expressed genes originated from the three replicates of GeneChip dataset ‘Lynx 72 h after mock inoculation’ were not recorded due to low quality of the microarrays.
GO terms enriched in genes that were significantly up-regulated in the resistant Dream cultivar at 32 and 72 h after inoculation (hai)
| | | ||||
|---|---|---|---|---|---|
| GO:0016165 | lipoxygenase activity | 0.03 | 0.00 | | |
| GO:0031408 | oxylipin biosynthetic process | 0.04 | 0.00 | | |
| GO:0009405 | pathogenesis | 0.10 | 0.01 | | |
| GO:0008610 | lipid biosynthetic process | 0.20 | 0.0 | | |
| GO:0004867 | serine-type endopeptidase inhibitor activity | 0.00 | 0.00 | 0.08 | 0.00 |
| GO:0004185 | serine-type carboxypeptidase activity | 0.05 | 0.00 | 0.20 | 0.01 |
| GO:0009611 | response to wounding | 0.15 | 0.00 | 0.21 | 0.00 |
| GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 0.23 | 0.01 | 0.07 | 0.00 |
| GO:0008233 | peptidase activity | 0.19 | 0.01 |
1) Significance levels for up-regulated GO terms: FDR value (False discovery rate) at < 0.25 (probability that gene set represents a false positive finding); NOM p-value (Statistical significance) at < 0.01 (gene-based permutation test).
GO terms enriched in genes that were significantly down-regulated in the resistant Dream cultivar at 72 h after inoculation (hai)
| | |||
|---|---|---|---|
| GO:0042254 | ribosomal chaperone activity | 0.00 | 0.00 |
| GO:0003735 | structural constituent of ribosome | 0.00 | 0.00 |
| GO:0006412 | translation | 0.00 | 0.00 |
| GO:0043581 | mycelium development | 0.00 | 0.00 |
| GO:0022626 | cellular component | 0.00 | 0.00 |
| GO:0022627 | cytosolic small ribosomal subunit | 0.00 | 0.00 |
| GO:0042973 | glucan endo-1,3-beta-D-glucosidase activity | 0.00 | 0.00 |
| GO:0030599 | pectinesterase activity | 0.03 | 0.00 |
| GO:0044425 | membrane part | 0.06 | 0.00 |
| GO:0015935 | small ribosomal subunit | 0.07 | 0.00 |
| GO:0008289 | lipid binding | 0.08 | 0.01 |
| GO:0006032 | chitin catabolic process | 0.08 | 0.01 |
| GO:0042575 | DNA polymerase complex | 0.13 | 0.00 |
| GO:0006260 | DNA replication | 0.15 | 0.01 |
| GO:0004568 | chitinase activity | 0.15 | 0.01 |
| GO:0015934 | large ribosomal subunit | 0.16 | 0.01 |
| GO:0016998 | cell wall macromolecule catabolic process | 0.17 | 0.01 |
| GO:0022625 | cytosolic large ribosomal subunit | 0.17 | 0.02 |
| GO:0005811 | lipid particle | 0.20 | 0.03 |
| GO:0006259 | DNA metabolic process | 0.21 | 0.02 |
1) Significance levels for down-regulated GO terms: FDR value (False discovery rate) at < 0.25 (probability that gene set represents a false positive finding); NOM p-value (Statistical significance) at < 0.01 (gene-based permutation test).
Figure 1Venn-diagrams of genes differentially expressed in cv. Dream after treatment and timepoint comparisons. (Sections A-C) Treatment comparison at 32 h after inoculation (hai) between 1,795 genes differentially expressed after ‘cv. Dream Fusarium inoculated versus cv. Lynx Fusarium inoculated’ and 1,700 genes differentially expressed after ‘cv. Dream mock inoculated versus cv. Lynx mock inoculated’. The Venn-diagram shows the numbers of differentially up- or down-regulated (+/−) genes that were assigned to the following categories of transcript occurrence: (Section A) FHB-responsive genes (656) were assumed to reflect induced cv. Dream-controlled differences between both cultivars as they were not differential expressed in the mock-inoculated controls of both cultivars and in the susceptible cv. Lynx after FHB treatment. (Section B) Genotype-specific genes (1,139) that were differentially expressed upon both treatments in cv. Dream, but not in cv. Lynx. (Section C) The remaining genes (561) were assumed to represent the genetic background of the Dream cultivar as they were also found to be differentially expressed in the absence of FHB-inoculation. For the timepoint 72 hai a corresponding categorisation could not be done due the low quality of the microarrays of the mock treated samples from the Lynx cultivar. (Sections D-F) Timepoint comparison for 1,795 genes differentially expressed after ‘cv. Dream Fusarium inoculated versus cv. Lynx Fusarium inoculated’ at 32 hai in reference to 1,737 genes differentially expressed after the analogous comparison at 72 hai. The Venn-diagram shows the numbers of differentially up- or down-regulated (+/−) genes at the certain timepoints: (Section D) Genes found to be differentially expressed in the cv. Dream exclusively at the timepoint 32 hai (752); (Section E) at both timepoints (1,043); and (Section F) exclusively at the timepoint 72 hai (694).
Numbers, classes and categories of genes differentially up- and down-regulated (+/−) in the resistant cv. Dream after inoculation (hai)
| | | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | ||
| | | | | | | | | | ||
| | JA and ET related genes | 5 | 3 | 3 | 0 | 0 | 0 | - | - | 11 |
| | Cysteine-rich Antimicrobial peptides | 4 | 2 | 1 | 0 | 0 | 0 | - | - | 7 |
| | Jasmonate-regulated proteins | 3 | 0 | 0 | 0 | 0 | 0 | - | - | 3 |
| | GDSL-lipases | 1 | 0 | 0 | 0 | 0 | 1 | - | - | 2 |
| | Proteolysis | 1 | 5 | 2 | 0 | 1 | 0 | - | - | 9 |
| | Peroxidases | 0 | 1 | 0 | 0 | 0 | 0 | - | - | 1 |
| | Genes related to cell wall defence | 4 | 2 | 4 | 0 | 3 | 0 | - | - | 13 |
| | Secondary metabolism/detoxification | 10 | 10 | 1 | 0 | 1 | 0 | - | - | 22 |
| | Miscellaneous defence related genes | 2 | 6 | 4 | 0 | 0 | 0 | - | - | 12 |
| | Transcription or signalling genes | 8 | 10 | 3 | 0 | 7 | 1 | - | - | 29 |
| | Hormone metabolism | 1 | 4 | 0 | 0 | 0 | 3 | - | - | 8 |
| Defence related (total) | 39 | 43 | 18 | 0 | 12 | 5 | - | - | 117 | |
| | Others | 51 | 117 | 23 | 0 | 27 | 2 | - | - | 220 |
| | Genes that have no information | 74 | 174 | 33 | 0 | 38 | 0 | - | - | 319 |
| Total | 163 | 333 | 81 | 0 | 77 | 2 | - | - | 656 | |
| | | | | | | | | | ||
| | JA and ET related genes | 3 | 3 | 6 | 0 | 4 | 0 | - | - | 16 |
| | Cysteine-rich Antimicrobial peptides | 3 | 1 | 5 | 0 | 0 | 0 | - | - | 9 |
| | Jasmonate-regulated proteins | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 |
| | GDSL-lipases | 3 | 2 | 7 | 0 | 2 | 0 | - | - | 14 |
| | Proteolysis | 2 | 0 | 11 | 0 | 5 | 0 | - | - | 18 |
| | Peroxidases | 2 | 6 | 2 | 0 | 0 | 0 | - | - | 10 |
| | Genes related to cell wall defence | 0 | 3 | 7 | 0 | 0 | 0 | - | - | 10 |
| | Secondary metabolism/detoxification | 5 | 8 | 15 | 0 | 12 | 0 | - | - | 40 |
| | Miscellaneous defence related genes | 0 | 3 | 4 | 0 | 5 | 0 | - | - | 12 |
| | Transcription or signalling genes | 3 | 7 | 17 | 0 | 14 | 0 | - | - | 41 |
| | Hormone metabolism | 0 | 1 | 0 | 0 | 2 | 0 | - | - | 3 |
| Defence related (total) | 21 | 34 | 74 | 0 | 44 | 0 | - | - | 173 | |
| | Others | 40 | 58 | 124 | 0 | 85 | 1 | - | - | 308 |
| | Genes that have no information | 37 | 66 | 337 | 0 | 217 | 1 | - | - | 658 |
| Total | 99 | 157 | 535 | 0 | 346 | 2 | - | - | 1,139 | |
| | | | | | | | | | ||
| | JA and ET related genes | - | - | - | - | - | - | 5 | 0 | 5 |
| | Cysteine-rich Antimicrobial peptides | - | - | - | - | - | - | 3 | 0 | 3 |
| | Jasmonate-regulated proteins | - | - | - | - | - | - | 0 | 0 | 0 |
| | GDSL-lipases | - | - | - | - | - | - | 1 | 0 | 1 |
| | Proteolysis | - | - | - | - | - | - | 4 | 3 | 7 |
| | Peroxidases | - | - | - | - | - | - | 4 | 2 | 6 |
| | Genes related to cell wall defence | - | - | - | - | - | - | 1 | 1 | 2 |
| | Secondary metabolism/detoxification | - | - | - | - | - | - | 20 | 4 | 24 |
| | Miscellaneous defence related genes | - | - | - | - | - | - | 6 | 0 | 6 |
| | Transcription or signalling genes | - | - | - | - | - | - | 15 | 8 | 23 |
| | Hormone metabolism | - | - | - | - | - | - | 4 | 1 | 5 |
| Defence related (total) | - | - | - | - | - | - | - | 19 | 82 | |
| | Others | - | - | - | - | - | - | 100 | 1 | 101 |
| | Genes that have no information | - | - | - | - | - | - | 270 | 241 | 511 |
| Total | - | - | - | - | - | - | 433 | 261 | 694 | |
| | | | | | | | | |||
1)Genes differentially expressed only at 72 hai were not mapped into one of the two categories ‘FHB-responsive genes’ and ‘Genotype-specific genes’, because of restrictions that originated in low quality of microarrays obtained from mock treated cv. Lynx samples at this timepoint (Table 1).
2)Numbers of unique genes are listed that were significantly differentially expressed genes (absolute t-value >1.96 and ≥ 2 fold change). Detailed information on the genes assigned to the different defence-related gene classes is provided in Additional files 1, 2 and 3.
BLASTN analyses of selected genes that were differentially expressed during incompatible cv. Dream–interactions
| Ta.1967.2.A1_x_at | Methyljasmonate-inducible lipoxygenase 2 | U56406 | Barley | 1) | 0.0 |
| TaAffx.104812.1.S1_s_at | Methyljasmonate-inducible lipoxygenase 2 | U56406 | Barley | 1) | 0.0 |
| Ta.13650.1.A1_at | ZmLOX6 | DQ335764 | Maize | 2) | 0.0 |
| Ta.1967.1.S1_x_at | Lox2 | AJ507212 | Barley | 3) | 5e-146 |
| Ta.485.1.A1_at | Lox2 (lox2:Hv:3 gene) | AJ507213 | Barley | 3) | 0.0 |
| Ta.22828.2.S1_at | Lox2 | GQ166691 | Wheat | 4) | 0.0 |
| TaAffx.90316.1.S1_at | ZmLOX2 | NM_001112503 | Maize | | 2e-87 |
| Ta.23763.1.S1_at | WCI-2 (Lipoxygenase) | U32428 | Wheat | 5) | 0.0 |
| Ta.188.1.S1_at | WCI-1 (Plant disease resistant response gene) | U32427 | Wheat | 5) | 0.0 |
| Ta.23967.1.S1_x_at | THI1.1 (alpha-1-purothionin) | X70665 | Wheat | 6) | 0.0 |
| Ta.20930.1.S1_at | PRPI-7 (Durum defensin precursor gene) | GQ449377 | Wheat | 7) | 3e-108 |
| Ta.28319.1.S1_at | TaTad1 mRNA for defensin | AB089942 | Wheat | 8) | 0.0 |
| Ta.21350.2.S1_at | wrsi5-1 (Bowman-Birk type protease inhibitor, putative) | AY549888 | Wheat | 9) | 3e-138 |
| Ta.30711.1.S1_x_at | wrsi5-1 (Bowman-Birk type protease inhibitor, putative) | AY549888 | Wheat | 9) | 0.0 |
| Ta.7843.1.S1_a_at | Non-specific lipid-transfer protein 4.3 precursor | HVU63993 | Barley | | 0.0 |
| Ta.31.1.S1_at | VER2 (Vernalization-related gene) | AB012103 | Wheat | 10) | 0.0 |
| TaAffx.128684.1.S1_at | ZmOPR2 (12-oxo-phytodienoate reductase 1) | AY921639 | Maize | 11) | 0.0 |
| Ta.30921.2.S1_at | ZmOPR4 (12-oxo-phytodienoate reductase 4) | AY921641 | Maize | 11) | 3e-144 |
a)Published sources: 1)[144]; 2)[52]; 3)[56]; 4)[145]; 5)[85]; 6)[67]; 7)[71]; 8)[70]; 9)[98]; 10)[89]; 11)[118].
b)For BLASTN analyses the threshold for a significant homology (‘Hit’) was set to an e-value ≤ 1e-20, Identity scale >70% according to [141].
Figure 2Expression analysis of the subtilisin-like serine protease inhibitor gene Ta.22614.1.S1_at in two cultivar pairs. Ta.22614.1.S1_at was analysed as a candidate gene for resistance against fungal-derived proteases. The qPCR time-course experiment was conducted on infected spikes of (A) the moderately FHB-resistant cv. Dream and the susceptible cv. Lynx; and (B) the FHB-resistant cv. Sumai 3 and the susceptible cv. Florence-Aurore. Fold increases were calculated relative to the internal standard gene (ubiquitin) and a water treated control sample (mock) of the respective sampling time using the comparative Ct-Method. Columns represent average induction (+SE, n = 3) plotted on a 2x logarithmic scale. Hash symbols indicate measurements where no gene expression was observed.
Presumed trichothecene-responsive genes with similar expression pattern during incompatible cv. Dream–interactions
| Ta.12887.1.S1_at | Trichothecene | UDP-glucosyltransferase HvUGT13248 | GU170355 | 1); 2); 3); 10); 12) |
| Ta.1811.1.S1_at | Trichothecene | UTP-glucosyltransferase | EU496513 | 3); 5) |
| Ta.23272.1.S1_at | Trichothecene | TaUGT3 (UDP-glucosyltransferase protein) | FJ236328 | 3) |
| Ta.8495.1.A1_at | Trichothecene | UDP-glucosyltransferase | AJ438338 | 3) |
| Ta.23340.2.S1_at | Trichothecene | cv. Sumai3 UDP-glucosyltransferase | HM133634 | 3) |
| Ta.22565.1.S1_at | Trichothecene | TaUGT1 (UDP-glucosyltransferase protein) | EU552210 | 3); 10) |
| " | " | TaUGT2 (UDP-glucosyltransferase protein) | EU568801 | |
| Ta.8232.1.A1_at | Trichothecene | TaPDR1 (pleiotropic drug resistance 1) | FJ185035 | 7) |
| Ta.6990.1.S1_at | Trichothecene | OsPDR5 (pleiotropic drug resistance 5), putative | FJ858380 | 9) |
| Ta.9385.3.S1_at | Trichothecene | Putative PDR-like ABC transporter related cluster | AY332479 | - |
| Ta.2793.1.S1_at | Trichothecene | TaMDR1 (MDR-like ABC transporter) | AB055077 | 1); 8) |
| TaAffx.91779.1.S1_at | Trichothecene | MRP (Multidrug Resistance-associated Protein) | | 4) |
| Ta.6621.1.A1_at | " | " | | |
| TaAffx.91779.2.S1_at | " | " | | |
| Ta.28932.1.S1_at | Trichothecene | MRP2 (Multidrug Resistance associated Protein 2) | AF532601 | 6) |
| Ta.27443.1.S1_at | Trichothecene | MRP3-like ABC transporter | | 1); 2) |
| TaAffx.12277.1.S1_at | Trichothecene | MATE efflux family protein b) | | 1) |
| Ta.4165.1.S1_at | Trichothecene | major facilitator superfamily antiporter, putative | | 1) |
| Ta.8990.1.S1_at | Oxidative burst | Glutaredoxin-like | | 1) |
| Ta.233.1.S1_at | Oxidative burst | AB078882 | 2) | |
| TaAffx.81871.1.S1_at | Regulatory | AAA-type ATPase | | 1) |
| Ta.3902.1.S1_at | Regulatory | AAA-type ATPase family protein | | 2) |
| Ta.7015.1.S1_at | Regulatory | F-box domain containing protein | | 1) |
| Ta.5155.1.S1_at | Defence | Putative blue copper binding protein | | 1) |
| Ta.8040.1.A1_at | Defence | Putative subtilisin-like serine proteinase | XM_003581069 | 1) |
| Ta.26151.1.A1_at | Defence | Putative subtilisin-like serine proteinase | | 1) |
| Ta.1207.1.S1_at | General | ZmOPR1 (12-oxo-phytodienoate reductase 1) | NM_001112429 | 1); 11) |
| Ta.19609.1.S1_at | General | cytochrome P450 | | 2) |
| Ta.8017.1.S1_at | Unknown | hypothetical protein | 2) |
a)Class association as obtained from respective literature sources.
b)Gene annotations were updated by BLASTN analysis in the NCBI database, otherwise published annotations were considered.
c)Published sources: 1)[106]; 2)[116]; 3)[4]; 4)[146]; 5)[109]; 6)[147]; 7)[108]; 8)[110]; 9)[107]; 10)[115]; 11)[118]; 12)[117].
d)Predicted MRP gene sequence contains EST cluster: CA732909, BJ309016 and BJ303163 [146].
Figure 3Analysis of gene expressions in the moderately FHB-resistant cv. Dream and the susceptible cv. Lynx. The qPCR time-course experiment was used to determine the expressions of six genes selected due to their proposed association to resistance against the F. graminearum-derived toxin deoxynivalenol (DON). Fold increases were calculated relative to the internal standard gene (ubiquitin) and a water treated control sample (mock) of the respective sampling time using the comparative Ct-Method. Columns represent average induction (+SE, n = 3) plotted on a 2x logarithmic scale. Hash symbols indicate measurements where no gene expression was observed.
Figure 4Analysis of gene expressions in the FHB-resistant cv. Sumai 3 and the susceptible cv. Florence-Aurore. The qPCR time-course experiment was used to determine the expressions of the six genes selected due to their proposed association to resistance against the F. graminearum-derived toxin deoxynivalenol (DON). Fold increases were calculated relative to the internal control gene (ubiquitin) and a water treated control sample (mock) of the respective sampling time using the comparative Ct-Method. Columns represent average induction (+SE, n = 3) plotted on a 2x logarithmic scale. Hash symbols above the bars indicate measurements where no gene expression was observed.